Literature DB >> 26115234

Solution Structure of CCL19 and Identification of Overlapping CCR7 and PSGL-1 Binding Sites.

Christopher T Veldkamp1,2, Eva Kiermaier3, Skylar J Gabel-Eissens1, Miranda L Gillitzer1, David R Lippner1, Frank A DiSilvio1, Casey J Mueller1, Paeton L Wantuch1, Gary R Chaffee1, Michael W Famiglietti1, Danielle M Zgoba1, Asha A Bailey1, Yaya Bah1, Samantha J Engebretson1, David R Graupner1, Emily R Lackner1, Vincent D LaRosa1, Tysha Medeiros1, Michael L Olson1, Andrew J Phillips1, Harley Pyles1, Amanda M Richard1, Scott J Schoeller1, Boris Touzeau1, Larry G Williams1, Michael Sixt3, Francis C Peterson2.   

Abstract

CCL19 and CCL21 are chemokines involved in the trafficking of immune cells, particularly within the lymphatic system, through activation of CCR7. Concurrent expression of PSGL-1 and CCR7 in naive T-cells enhances recruitment of these cells to secondary lymphoid organs by CCL19 and CCL21. Here the solution structure of CCL19 is reported. It contains a canonical chemokine domain. Chemical shift mapping shows the N-termini of PSGL-1 and CCR7 have overlapping binding sites for CCL19 and binding is competitive. Implications for the mechanism of PSGL-1's enhancement of resting T-cell recruitment are discussed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26115234      PMCID: PMC4809050          DOI: 10.1021/acs.biochem.5b00560

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

Review 1.  Structure, function, and inhibition of chemokines.

Authors:  Elias J Fernandez; Elias Lolis
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

2.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

3.  Coy decoy with a new ploy: interceptor controls the levels of homeostatic chemokines.

Authors:  Guttorm Haraldsen; Antal Rot
Journal:  Eur J Immunol       Date:  2006-07       Impact factor: 5.532

4.  Involvement of chemokine receptors in breast cancer metastasis.

Authors:  A Müller; B Homey; H Soto; N Ge; D Catron; M E Buchanan; T McClanahan; E Murphy; W Yuan; S N Wagner; J L Barrera; A Mohar; E Verástegui; A Zlotnik
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

5.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

Authors:  D Finzi; M Hermankova; T Pierson; L M Carruth; C Buck; R E Chaisson; T C Quinn; K Chadwick; J Margolick; R Brookmeyer; J Gallant; M Markowitz; D D Ho; D D Richman; R F Siliciano
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

6.  Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs.

Authors:  Krystle M Veerman; Michael J Williams; Kenji Uchimura; Mark S Singer; Jasmeen S Merzaban; Silvia Naus; Douglas A Carlow; Philip Owen; Jesús Rivera-Nieves; Steven D Rosen; Hermann J Ziltener
Journal:  Nat Immunol       Date:  2007-04-01       Impact factor: 25.606

7.  Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.

Authors:  M P Crump; J H Gong; P Loetscher; K Rajarathnam; A Amara; F Arenzana-Seisdedos; J L Virelizier; M Baggiolini; B D Sykes; I Clark-Lewis
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

8.  Chondroitin sulfate B exerts its inhibitory effect on secondary lymphoid tissue chemokine (SLC) by binding to the C-terminus of SLC.

Authors:  Jun Hirose; Hiroto Kawashima; Melissa Swope Willis; Timothy A Springer; Hitoshi Hasegawa; Osamu Yoshie; Masayuki Miyasaka
Journal:  Biochim Biophys Acta       Date:  2002-07-03

9.  Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12.

Authors:  Christopher T Veldkamp; Christoph Seibert; Francis C Peterson; Norberto B De la Cruz; John C Haugner; Harihar Basnet; Thomas P Sakmar; Brian F Volkman
Journal:  Sci Signal       Date:  2008-09-16       Impact factor: 8.192

Review 10.  CCR7 and its ligands: balancing immunity and tolerance.

Authors:  Reinhold Förster; Ana Clara Davalos-Misslitz; Antal Rot
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

View more
  18 in total

Review 1.  PSGL-1: A New Player in the Immune Checkpoint Landscape.

Authors:  Roberto Tinoco; Dennis C Otero; Amy A Takahashi; Linda M Bradley
Journal:  Trends Immunol       Date:  2017-03-02       Impact factor: 16.687

Review 2.  Emerging patterns of tyrosine sulfation and O-glycosylation cross-talk and co-localization.

Authors:  Akul Y Mehta; Jamie Heimburg-Molinaro; Richard D Cummings; Christoffer K Goth
Journal:  Curr Opin Struct Biol       Date:  2020-01-09       Impact factor: 6.809

3.  Preparation and Analysis of N-Terminal Chemokine Receptor Sulfopeptides Using Tyrosylprotein Sulfotransferase Enzymes.

Authors:  Christoph Seibert; Anthony Sanfiz; Thomas P Sakmar; Christopher T Veldkamp
Journal:  Methods Enzymol       Date:  2015-11-14       Impact factor: 1.600

4.  CK12a, a CCL19-like Chemokine That Orchestrates both Nasal and Systemic Antiviral Immune Responses in Rainbow Trout.

Authors:  Ali Sepahi; Luca Tacchi; Elisa Casadei; Fumio Takizawa; Scott E LaPatra; Irene Salinas
Journal:  J Immunol       Date:  2017-10-23       Impact factor: 5.422

Review 5.  VISTA: Coming of age as a multi-lineage immune checkpoint.

Authors:  M A ElTanbouly; E Schaafsma; R J Noelle; J L Lines
Journal:  Clin Exp Immunol       Date:  2020-02-04       Impact factor: 4.330

6.  Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1-Resistant Melanoma.

Authors:  Karla M Viramontes; Emily N Neubert; Julia M DeRogatis; Monique L Henriquez; Christian F Guerrero-Juarez; Roberto Tinoco
Journal:  Cancer Immunol Res       Date:  2022-05-03       Impact factor: 12.020

7.  Polysialylation controls dendritic cell trafficking by regulating chemokine recognition.

Authors:  Eva Kiermaier; Christine Moussion; Christopher T Veldkamp; Rita Gerardy-Schahn; Ingrid de Vries; Larry G Williams; Gary R Chaffee; Andrew J Phillips; Friedrich Freiberger; Richard Imre; Deni Taleski; Richard J Payne; Asolina Braun; Reinhold Förster; Karl Mechtler; Martina Mühlenhoff; Brian F Volkman; Michael Sixt
Journal:  Science       Date:  2015-12-10       Impact factor: 47.728

8.  Crystallographic Structure of Truncated CCL21 and the Putative Sulfotyrosine-Binding Site.

Authors:  Emmanuel W Smith; Eric M Lewandowski; Natasha A Moussouras; Kyle G Kroeck; Brian F Volkman; Christopher T Veldkamp; Yu Chen
Journal:  Biochemistry       Date:  2016-09-26       Impact factor: 3.162

9.  Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding.

Authors:  Austin J Barmore; Sally M Castex; Brittany A Gouletas; Alex J Griffith; Slater W Metz; Nicolas G Muelder; Michael J Populin; David M Sackett; Abigail M Schuster; Christopher T Veldkamp
Journal:  Biochem Biophys Res Commun       Date:  2016-06-21       Impact factor: 3.575

10.  Structural Features of an Extended C-Terminal Tail Modulate the Function of the Chemokine CCL21.

Authors:  Natasha A Moussouras; Gertrud M Hjortø; Francis C Peterson; Martyna Szpakowska; Andy Chevigné; Mette M Rosenkilde; Brian F Volkman; Michael B Dwinell
Journal:  Biochemistry       Date:  2020-03-26       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.